Menopausal Hormone Therapy: Clinical Benefits and Outcome Studies, A Deep Dive into the Evidence

Since the 2002 Women’s Health Initiative (WHI) publication, menopausal hormone therapy (MHT), especially estrogen (E)/estradiol (E2) replacement therapy (ERT), has been hotly debated. The WHI’s preliminary data release changed clinician practice patterns. Since then, clinicians have struggled with weighing the benefits with the risks. Since women spend approximately 1/3 of their lives hormone insufficient/deficient, it is important to understand MHT’s benefits and risks. This non-CME webinar will review the limitations of hormone-related guidelines, while demonstrating how the clinical evidence guides prescribing micronized progesterone, estradiol, and testosterone therapy, as well as which delivery methods and doses improve clinical outcomes.

This non-CME webinar will review the limitations of hormone-related guidelines, while demonstrating how the clinical evidence guides prescribing micronized progesterone, estradiol, and testosterone therapy, as well as which delivery methods and doses improve clinical outcomes.

[gisellealvarado]

Only 29 people have listened to this, wow, I’m a so grateful I found this and it’s free❤, thank you for sharing and educating us!!!!

[deepakeshavan]

Amazing presentation 👏 I couldn't have found this much information anywhere else. As a perimenopausal woman and a practicing gynecologist I really appreciate all you have compiled and presented

[vyvyienewalser]

Excuse me...U show the slides and diagrams to higher educated women.Really.Why not explain it to every patient .Just pushing this dutch testing and making money.So glad this was made public.